Quick Answer
MediWound Ltd. reported Research And Development Expense of $14.32 million for the year ending 2025.
- MediWound Ltd. showed an increase of +61.3% in Research And Development Expense from 2024 to 2025.
- This data is from MediWound Ltd.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), MediWound Ltd.'s Research And Development Expense has grown by 137.8%.
- Historical annual values: Fiscal year 2025: $14.32 million | Fiscal year 2024: $8.88 million | Fiscal year 2023: $7.47 million | Fiscal year 2022: $10.18 million | Fiscal year 2021: $10.26 million | Fiscal year 2020: $7.70 million | Fiscal year 2019: $4.97 million | Fiscal year 2018: $4.07 million | Fiscal year 2017: $5.46 million | Fiscal year 2016: $7.07 million | Fiscal year 2015: $6.02 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: